Get started
Author

Her‐Shyong Shiah

Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC: Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial
2021 · Shun Lu, Qiming Wang, et al. · Journal of Thoracic Oncology · 151
PDF
Impact of sodium-glucose cotransporter-2 inhibitors on heart failure and mortality in patients with cancer
2022 · Cho-Han Chiang, Cho-Hung Chiang, et al. · Heart · 61
PDF
Effects of a novel tylophorine analog on collagen‐induced arthritis through inhibition of the innate immune response
2006 · Xin You, Meng Pan, et al. · Arthritis & Rheumatism · 57
Abrogation of skin disease in LUPUS‐prone MRL/FAS lpr mice by means of a novel tylophorine analog
2006 · Jin‐Young Choi, Wenli Gao, et al. · Arthritis & Rheumatism · 38
The incidence and risk of cardiovascular events associated with immune checkpoint inhibitors in Asian populations
2022 · Cho-Han Chiang, Cho-Hung Chiang, et al. · Japanese Journal of Clinical Oncology · 35
Abstract CT190: A multicenter, open-label, single-arm, phase II study: The third generation EGFR tyrosine kinase inhibitor almonertinib for pretreated EGFR T790M-positive locally advanced or metastatic non-small cell lung cancer (APOLLO)
2020 · Shun Lu, Qiming Wang, et al. · Cancer Research · 25
Effects of Dang-Gui-Bu-Xue-Tang, an herbal decoction, on iron uptake in iron-deficient anemia
2016 · Ching-Chiung Wang, Guan-Cheng Huang, et al. · Drug Design Development and Therapy · 25
PDF
The impact of sodium‐glucose cotransporter‐2 inhibitors on outcome of patients with diabetes mellitus and colorectal cancer
2024 · Cho‐Han Chiang, Cho‐Han Chiang, et al. · Journal of Gastroenterology and Hepatology · 24
PDF
Tamoxifen accelerates proteasomal degradation of O6‐methylguanine DNA methyltransferase in human cancer cells
2007 · Ching‐Chuan Kuo, Jin‐Fen Liu, et al. · International Journal of Cancer · 24
Combination of arsenic trioxide and BCNU synergistically triggers redox-mediated autophagic cell death in human solid tumors
2011 · Ching-Chuan Kuo, Tsang-Wu Liu, et al. · Free Radical Biology and Medicine · 22
Effect of ethanol on hepatotoxicity and hepatic DNA-binding of aflatoxin B1 in rats
1990 · Chau-Jong Wang, Shao-Win Wang, et al. · Biochemical Pharmacology · 19
Evaluation of combination treatment with DS-1205c, an AXL kinase inhibitor, and osimertinib in metastatic or unresectable EGFR-mutant non-small cell lung cancer: results from a multicenter, open-label phase 1 study
2023 · James Chih-Hsin Yang, Wu-Chou Su, et al. · Investigational New Drugs · 9
PDF
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48‐h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
2005 · HUI‐JU CH’ANG, CHUAN‐CHENG WANG, et al. · Journal of Gastroenterology and Hepatology · 9
Phase I study of biweekly liposome irinotecan (PEP02, MM-398) in metastatic colorectal cancer failed on first-line oxaliplatin-based chemotherapy.
2012 · Li-Tzong Chen, Her-Shyong Shiah, et al. · Journal of Clinical Oncology · 8
Phase I–II trial of weekly gemcitabine plus high‐dose 5‐fluorouracil and leucovorin in advanced pancreatic cancer
2005 · HER‐SHYONG SHIAH, ANN‐LII CHENG, et al. · Journal of Gastroenterology and Hepatology · 8
Chemopreventive effects of Xiang Sha Liu Jun Zi Tang on paclitaxel-induced leucopenia and neuropathy in animals
2023 · Her-Shyong Shiah, Chia-Jung Lee, et al. · Frontiers in Pharmacology · 5
PDF
Oral paclitaxel and encequidar in patients with breast cancer: a pharmacokinetic, safety, and antitumor activity study
2023 · Ming-Shen Dai, Ta-Chung Chao, et al. · Therapeutic Advances in Medical Oncology · 5
PDF
The impact of cationic amphiphilic antihistamines on patients with lung cancer receiving immunotherapy.
2023 · Cho Hung Chiang, Cho Han Chiang, et al. · Journal of Clinical Oncology · 4
AdvanTIG-105: A phase 1b dose-expansion study of ociperlimab (OCI) + tislelizumab (TIS) with chemotherapy (chemo) in patients (pts) with stage IV gastric/gastroesophageal adenocarcinoma (GC/GEJC).
2023 · Se Hyun Kim, Gyeong-Won Lee, et al. · Journal of Clinical Oncology · 3
PDF
AdvanTIG-105: Phase 1b dose-expansion study of ociperlimab (OCI) + tislelizumab (TIS) with chemotherapy (chemo) in patients (pts) with stage IV gastric/gastroesophageal adenocarcinoma (GC/GEJC).
2023 · Sae Hyun Kim, Gyeong-Won Lee, et al. · JCO Global Oncology · 2
Effectiveness of Stereotactic Ablative Radiotherapy for Systemic Therapy Respondents with Inoperable Pulmonary Oligometastases and Oligoprogression
2023 · Chin-Beng Ho, Jo-Ting Tsai, et al. · Diagnostics · 2
PDF
Concurrent chemoradiotherapy with cetuximab plus twice-weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal squamous cell carcinoma.
2013 · Chia-Chi J. Lin, Chih-Hung Hsu, et al. · Journal of Clinical Oncology · 2
Abstract CT167: Trial in progress: Phase 1 dose escalation study of T-1101, a first-in-class oral Hec1/Nek2 inhibitor, in patients with advanced refractory solid tumors
2024 · Wu-Chou Su, Li-Yuan Bai, et al. · Cancer Research · 1
Clinical performance of Bladder EpiCheck methylation test for active surveillance of non-muscle invasive bladder cancer: Systematic review and meta-analysis.
2023 · YUANPING HSIA, Cho Hsien Chiang, et al. · Journal of Clinical Oncology · 1
PDF
Immune checkpoint inhibitors-associated periodontitis: A propensity score-matched retrospective cohort study.
2023 · Yuanping Hsia, Cho Hsien Chiang, et al. · Journal of Clinical Oncology · 1
PDF
Works count: 37
Citation count: 545
H-index: 11
I10-index: 11
Year
Topic
Type